Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001498428-26-000007

CEO & President sold 5,513 shares at $16.82 ($92,729)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Cox John · CEO & President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-13 Sale : show line 1 in the form 10b5-1 −5,513 $16.82 $92,729 351,994 D
Open-market sales · 5,513 sh · avg $16.82 · $92,729
Loading xslF345X06/ownership.xml…